{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:18:44Z","timestamp":1762917524860},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T00:00:00Z","timestamp":1406592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s13730-014-0127-0","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T08:37:44Z","timestamp":1406536664000},"page":"237-243","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis"],"prefix":"10.1007","volume":"3","author":[{"given":"Shunsuke","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tsuchimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Kaizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ooboshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,29]]},"reference":[{"key":"127_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"D Scott","year":"2010","unstructured":"Scott D, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094\u2013108.","journal-title":"Lancet"},{"key":"127_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1741-7015-11-95","volume":"11","author":"A Kronbichler","year":"2013","unstructured":"Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Med. 2013;11:95.","journal-title":"BMC Med"},{"key":"127_CR3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.1780380213","volume":"38","author":"HJ Helin","year":"1995","unstructured":"Helin HJ, Korpela MM, Mstonen JT, Pasternack AI. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum. 1995;38:242\u20137.","journal-title":"Arthritis Rheum"},{"key":"127_CR4","unstructured":"Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall\u2019s renal pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 587\u201392."},{"issue":"Suppl 6","key":"127_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/rheumatology\/kes278","volume":"51","author":"KS Upchurch","year":"2012","unstructured":"Upchurch KS, Kay J. Evolution of treatment for rheumatoid arthritis. Rheumatology (Oxford). 2012;51(Suppl 6):28\u201336.","journal-title":"Rheumatology (Oxford)"},{"key":"127_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.semarthrit.2012.11.007","volume":"43","author":"RJ Maneiro","year":"2013","unstructured":"Maneiro RJ, Salgado E, Carona L, Gomez-Reino JJ. Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: systematic review and meta-analysis. Semin Arthritis Rheum. 2013;43:9\u201317.","journal-title":"Semin Arthritis Rheum"},{"key":"127_CR7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","volume":"371","author":"JS Smolen","year":"2008","unstructured":"Smolen JS, Beaulieu A, Robber-Roth A, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomized trial. Lancet. 2008;371:987\u201397.","journal-title":"Lancet"},{"key":"127_CR8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/0886022X.2013.773913","volume":"35","author":"MD Rendondo-Pach\u00f3n","year":"2013","unstructured":"Rendondo-Pach\u00f3n MD, Enr\u00edquez R, Sirvent AE, et al. Tocilizumab treatment for nephrotic syndrome due to amyloidosis in Behcet\u2019s disease. Ren Fail. 2013;35:547\u201350.","journal-title":"Ren Fail"},{"key":"127_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/13506129.2011.613962","volume":"18","author":"C Magro-Checa","year":"2011","unstructured":"Magro-Checa C, Navas-Parejo Casado A, Borrego-Garc\u00eda E, et al. Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis. Amyloid. 2011;18:235\u20139.","journal-title":"Amyloid"},{"key":"127_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/RHU.0b013e318293793c","volume":"19","author":"JP Vinicki","year":"2013","unstructured":"Vinicki JP, De Rosa G, Laborder HA. Renal amyloidosis secondary to rheumatoid arthritis: remission of proteinuria and renal function improvement with tocilizumab. J Clin Rheumatol. 2013;19:211\u20133.","journal-title":"J Clin Rheumatol"},{"key":"127_CR11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ndt\/gfr357","volume":"27","author":"T Ueno","year":"2012","unstructured":"Ueno T, Takeda K, Nagata M. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis. Nephrol Dial Transpl. 2012;27:633\u20139.","journal-title":"Nephrol Dial Transpl"},{"key":"127_CR12","doi-asserted-by":"crossref","unstructured":"Iijima T, Suwabe T, Sumida K, et al. Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis. Mod Rheumatol. 2014. (in press).","DOI":"10.3109\/14397595.2013.874748"},{"key":"127_CR13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2169\/internalmedicine.51.6555","volume":"51","author":"N Otani","year":"2012","unstructured":"Otani N, Morishita Y, Oh I, et al. Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman\u2019s disease by an anti-interleukin-6 receptor antibody (tocilizumab). Intern Med. 2012;51:1375\u20138.","journal-title":"Intern Med"},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/rheumatology\/ker222","volume":"50","author":"K Sumida","year":"2011","unstructured":"Sumida K, Ubara Y, Suwabe T, et al. Complete remission of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis complicated with rheumatoid arthritis using a humanized anti-interleukin 6 receptor antibody. Rheumatology (Oxford). 2011;50:1928\u201330.","journal-title":"Rheumatology (Oxford)"},{"key":"127_CR15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","volume":"265","author":"PC Heinrich","year":"1990","unstructured":"Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621\u201336.","journal-title":"Biochem J"},{"key":"127_CR16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-291X(88)81056-8","volume":"155","author":"HJ Moshage","year":"1988","unstructured":"Moshage HJ, Roelofs HM, van Pelt JF, et al. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun. 1988;155:112\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"127_CR17","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.4049\/jimmunol.144.9.3347","volume":"144","author":"GS Firestein","year":"1990","unstructured":"Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol. 1990;144:3347\u201353.","journal-title":"J Immunol"},{"key":"127_CR18","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","volume":"118","author":"FM Brennan","year":"2008","unstructured":"Brennan FM, Mclnnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118:3537\u201345.","journal-title":"J Clin Invest"},{"key":"127_CR19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1172\/JCI114749","volume":"86","author":"SJ Brandt","year":"1990","unstructured":"Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman\u2019s disease in mice. J Clin Invest. 1990;86:592\u20139.","journal-title":"J Clin Invest"},{"issue":"Suppl 3","key":"127_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ndt\/gfr245","volume":"27","author":"D Xu","year":"2012","unstructured":"Xu D, Lv J, Dong Y, et al. Renal involvement in a large cohort of Chinese patients with Castleman disease. Nephrol Dial Transpl. 2012;27(Suppl 3):119\u201325.","journal-title":"Nephrol Dial Transpl"},{"key":"127_CR21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/0961203312441046","volume":"21","author":"K Maeshima","year":"2012","unstructured":"Maeshima K, Ishii K, Torigoe M, et al. Successful tocilizumab and tacrolimus treatment in a patient with rheumatoid arthritis complicated by systemic lupus erythematosus. Lupus. 2012;21:1003\u20136.","journal-title":"Lupus"},{"key":"127_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00272437","volume":"8","author":"EJ Borg ter","year":"1988","unstructured":"ter Borg EJ, Janssen S, van Rijswijk MH, et al. AA amyloidosis associated with systemic lupus erythematosus. Rheumatol Int. 1988;8:141\u20133.","journal-title":"Rheumatol Int"},{"key":"127_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5414\/CNP70464","volume":"70","author":"K Masutani","year":"2008","unstructured":"Masutani K, Nagata M, Ikeda H, et al. Glomerular crescent formation in renal amyloidosis. A clinicopathological study and demonstration of upregulated cell-mediated immunity. Clin Nephrol. 2008;70:464\u201374.","journal-title":"Clin Nephrol"},{"key":"127_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1440-1827.2001.01188.x","volume":"51","author":"M Nagata","year":"2001","unstructured":"Nagata M, Shimokama T, Harada A, Koyama A, Watanabe T. Glomerular crescents in renal amyloidosis: an epiphenomenon or distinct pathology? Pathol Int. 2001;51:179\u201386.","journal-title":"Pathol Int"},{"key":"127_CR25","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.humpath.2007.04.013","volume":"38","author":"J Verine","year":"2007","unstructured":"Verine J, Mourad N, Desseaux K, et al. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol. 2007;38:1798\u2013809.","journal-title":"Hum Pathol"},{"key":"127_CR26","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(13)60250-0","volume":"381","author":"C Gabay","year":"2013","unstructured":"Gabay C, Emery P, van Vollenhoven R, et al. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomized, double blind, controlled phase 4 trial. Lancet. 2013;381:1541\u201350.","journal-title":"Lancet"},{"key":"127_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/14397595.2013.854048","volume":"24","author":"Y Okuda","year":"2014","unstructured":"Okuda Y, Ohnishi M, Matoba K, et al. Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases. Mod Rheumatol. 2014;24:137\u201343.","journal-title":"Mod Rheumatol"},{"key":"127_CR28","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3899\/jrheum.120325","volume":"39","author":"K Nishimura","year":"2012","unstructured":"Nishimura K, Saegusa J, Kawano S, Morinobu A. Tumor necrosis factor-\u03b1 inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis. J Rheumatol. 2012;39:1904\u20135.","journal-title":"J Rheumatol"},{"key":"127_CR29","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/rheumatology\/kes403","volume":"52","author":"Y Matsuo","year":"2013","unstructured":"Matsuo Y, Mizoguchi F, Kohsaka H, Ito E, Eshii Y, Miyasaka N. Tocilizumab-induced immune complex glomerulonephritis in a patient with rheumatoid arthritis. Rheumatology (Oxford). 2013;52:1341\u20133.","journal-title":"Rheumatology (Oxford)"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0127-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-014-0127-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0127-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T14:26:55Z","timestamp":1689431215000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-014-0127-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,29]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s13730-014-0127-0","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,29]]}}}